Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

When making decisions about adjuvant chemotherapy for early-stage breast cancer, costs and benefits of treatment should be carefully weighed. In this process, patients' preferences are of major importance. The objectives of the present study were: (1) to determine the minimum benefits that pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, S J T, Kievit, J, Nooij, M A, Haes, J C J M de, Overpelt, I M E, Slooten, H van, Maartense, E, Stiggelbout, A M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363690/
https://www.ncbi.nlm.nih.gov/pubmed/11401308
http://dx.doi.org/10.1054/bjoc.2001.1836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363690/
https://www.ncbi.nlm.nih.gov/pubmed/11401308
http://dx.doi.org/10.1054/bjoc.2001.1836

Ejemplares similares